In June 2019 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the bodybuilder Deepu D.K. after his sample tested positive for the prohibited substances Canrenone, Drostanolone, Mephentermine, Phentermine and Stanozolol.
After notification a provisional suspension was ordered and the Athlete filed a statement in his defence.
In his submission the Athlete denied the intentional use of the substances and stated that he had used medication for his condition. Hereafter he failed to respond to the INADA communications nor did he attend the hearing the Anti-Doping Disciplinary Panel of India (ADDPI).
The Panel finds that the test result showed the presence of prohibited substances in the Athlete’s sample and accordingly that he committed an anti-doping rule violation. Without the Athlete’s response the Panel concludes that he failed to establish that the violation was not intentional nor how the prohibited substances entered his system.
Therefore the Panel decides on 3 January 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 4 June 2019.
